Amyotrophic Lateral Sclerosis (ALS) in Respiratory Care

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that damages the motor neurons responsible for voluntary muscle movement. As these neurons deteriorate, patients develop increasing weakness that eventually affects mobility, swallowing, coughing, and breathing.

Respiratory complications are particularly important because progressive weakness of the diaphragm and other respiratory muscles can lead to ineffective airway clearance, nocturnal hypoventilation, and eventually respiratory failure.

Careful respiratory monitoring, assisted coughing, noninvasive ventilation, and long-term supportive care can help maintain ventilation, reduce complications, and improve quality of life as the disease progresses.

What Is Amyotrophic Lateral Sclerosis?

Amyotrophic lateral sclerosis is a progressive motor neuron disease characterized by degeneration of upper and lower motor neurons in the brain and spinal cord. It is also commonly known as Lou Gehrig disease.

Motor neurons transmit signals from the nervous system to skeletal muscles. When these neurons are damaged, the muscles they control gradually weaken and lose function. Over time, progressive muscle weakness can affect nearly every voluntary muscle group in the body.

ALS may initially involve a localized region before spreading. Weakness commonly begins in the arms or legs, although some patients initially develop symptoms involving the muscles responsible for speech and swallowing.

Approximately one quarter of patients may develop initial symptoms involving the bulbar muscles. These muscles contribute to:

• Speech
• Swallowing
• Glottic closure
• Airway protection
• Coughing

Less commonly, ALS may initially present with diaphragmatic dysfunction.

Regardless of where symptoms begin, respiratory muscle involvement eventually develops in most patients. Progressive respiratory weakness is one of the most important complications of ALS and is a major cause of morbidity and mortality.

How ALS Affects the Respiratory System

The lungs depend on an effective ventilatory pump to move air into and out of the respiratory system. This pump includes the diaphragm, intercostal muscles, abdominal muscles, rib cage, and accessory respiratory muscles.

In ALS, the lungs themselves may initially be relatively normal. The primary respiratory problem is weakness of the muscles required to generate ventilation. As respiratory muscle strength declines, patients become increasingly unable to generate the pressures needed to produce adequate tidal volumes and maintain effective alveolar ventilation.

Respiratory weakness may eventually result in:

• Decreased vital capacity
• Reduced total lung capacity
• Reduced inspiratory flow
• Shallow breathing
• Ineffective coughing
• Retained secretions
• Atelectasis
• Ventilation-perfusion abnormalities
• Hypoxemia
• Hypercapnia
• Respiratory acidosis
• Respiratory failure

Note: The respiratory effects of ALS generally progress gradually, allowing respiratory therapists and other clinicians to monitor changes and introduce supportive therapies before severe respiratory failure occurs.

Stages of Respiratory Dysfunction in ALS

Respiratory deterioration in ALS can be understood as a progression through several functional stages.

Normal Respiratory Function

During the earliest stage, the patient may have little or no noticeable respiratory impairment. This period provides an opportunity to establish baseline measurements that can later be compared with repeat testing.

Important baseline assessments include:

• Oxygen saturation
• Forced vital capacity
• Vital capacity
• Forced expiratory volume in one second
• Maximum inspiratory pressure
• Maximum expiratory pressure
• Peak cough flow

Note: Serial measurements are generally more useful than a single isolated value because ALS progresses over time.

Adequate Ventilation With an Ineffective Cough

A patient may continue to maintain adequate ventilation while losing the ability to cough effectively. This occurs because coughing requires significant inspiratory and expiratory muscle strength. Once these muscles weaken, secretions may become difficult to mobilize.

Assisted coughing and lung-volume recruitment become increasingly important during this stage.

Adequate Daytime Ventilation With Nocturnal Hypoventilation

Sleep-related hypoventilation commonly appears before daytime respiratory failure. The respiratory system is placed under different conditions during sleep, and weakened respiratory muscles may become unable to maintain adequate alveolar ventilation.

Patients may therefore develop hypercapnia and oxygen desaturation at night while daytime gas exchange remains relatively acceptable.

Inadequate Daytime and Nighttime Ventilation

During advanced respiratory involvement, ventilation becomes insufficient both while awake and during sleep.

Patients may require extended noninvasive ventilatory support, continuous ventilatory assistance, or invasive mechanical ventilation through a tracheostomy depending on their condition and goals of care.

Respiratory Symptoms of ALS

Respiratory symptoms may initially be subtle. One of the earliest manifestations is exertional dyspnea. Patients may notice shortness of breath while walking, climbing stairs, bathing, dressing, or performing other activities that previously caused little difficulty.

As diaphragmatic weakness progresses, orthopnea may develop. Orthopnea refers to shortness of breath that worsens when lying flat. This occurs because the abdominal contents move upward against the diaphragm when the patient assumes the supine position.

A weakened diaphragm may be unable to overcome this additional mechanical disadvantage. Patients with severe diaphragmatic weakness may therefore prefer sleeping with the head elevated or sitting upright.

Other symptoms associated with respiratory muscle weakness and hypoventilation may include:

• Fatigue
• Morning headaches
• Daytime sleepiness
• Poor concentration
• Dyspnea
• Disturbed sleep
• Frequent nighttime awakenings
• Weak cough
• Difficulty clearing secretions

Note: Morning headaches can occur because carbon dioxide accumulates during periods of nocturnal hypoventilation.

Pulmonary Function Changes in ALS

ALS generally produces a restrictive pattern of pulmonary impairment because weakened respiratory muscles cannot fully expand or empty the lungs. Vital capacity and total lung capacity progressively decline as inspiratory muscle strength deteriorates.

Residual volume may remain relatively preserved or become proportionally elevated because weakened expiratory muscles prevent complete lung emptying.

Functional residual capacity may remain relatively normal because the elastic properties of the lungs and chest wall are not necessarily altered early in the disease.

A typical neuromuscular pattern may therefore include:

• Decreased vital capacity
• Decreased total lung capacity
• Relatively preserved functional residual capacity
• Relatively increased residual volume
• Increased RV/TLC ratio

Note: This pattern differs from many forms of intrinsic restrictive lung disease, in which several lung volumes may decrease together.

Vital Capacity

Vital capacity is one of the most useful measurements for monitoring respiratory decline in ALS. It provides an overall indication of the patient’s ability to move a maximal amount of air using the respiratory muscles.

Progressive decreases in vital capacity indicate worsening respiratory muscle weakness.

A vital capacity below approximately 10 to 15 mL/kg predicted body weight represents severely reduced ventilatory reserve and may indicate impending or established respiratory failure.

A value below approximately 1 L is also concerning, particularly when accompanied by respiratory distress, hypercapnia, or significant weakness. Vital capacity should always be interpreted with the patient’s overall clinical presentation.

Upright and Supine Vital Capacity

Comparing vital capacity in upright and supine positions can help identify diaphragmatic weakness. When a patient lies flat, the abdominal contents shift toward the diaphragm. A healthy diaphragm can compensate for this change, but a weakened diaphragm may not.

A decrease of approximately 10% to 20% in vital capacity when moving from sitting to supine may suggest diaphragmatic dysfunction.

A decrease of approximately 25% provides stronger evidence of clinically important diaphragm weakness. This positional change may help explain why patients with ALS frequently develop orthopnea.

Maximum Inspiratory Pressure

Maximum inspiratory pressure, or MIP, measures inspiratory muscle strength. It is also sometimes referred to clinically as negative inspiratory force. During the test, the patient exhales and then attempts to inhale forcefully against an occluded airway.

The amount of negative pressure generated provides information about the strength of the diaphragm, intercostal muscles, and accessory inspiratory muscles. As ALS progresses, MIP generally becomes less negative.

An MIP that becomes less negative than approximately −20 to −25 cm H₂O suggests severe inspiratory muscle weakness and may indicate that the patient can no longer maintain adequate spontaneous ventilation. The measurement must be interpreted carefully because it depends heavily on patient effort and cooperation.

Maximum Expiratory Pressure

Maximum expiratory pressure, or MEP, evaluates the strength of expiratory muscles. The patient inhales maximally and then exhales forcefully against an occluded airway.

MEP reflects the function of the abdominal muscles and other muscles involved in forced expiration. Expiratory strength is particularly important because coughing depends on the ability to generate high intrathoracic pressure.

An MEP below approximately 60 cm H₂O may indicate that cough assistance should be considered. Values below approximately 40 cm H₂O suggest more severe expiratory weakness.

Sniff Nasal Inspiratory Pressure

Sniff nasal inspiratory pressure, or SNIP, provides another method for evaluating inspiratory muscle strength. During the maneuver, one nostril is occluded while the patient performs a forceful sniff through the other nostril.

The resulting pressure is measured and used as an indication of inspiratory muscle function. SNIP can be particularly useful as a complementary measurement in patients with neuromuscular disorders.

A sniff nasal inspiratory pressure below approximately 40 cm H₂O has been associated with poor prognosis in ALS. Like other respiratory muscle tests, the value should be interpreted together with symptoms, vital capacity, gas exchange, and other clinical findings.

Ineffective Cough in ALS

An effective cough requires several coordinated steps. First, the patient must inhale a sufficiently large breath. Next, the glottis closes while expiratory muscles contract and increase intrathoracic pressure. The glottis then opens rapidly, allowing high expiratory flow to move secretions toward the upper airway.

ALS may impair each part of this process. Inspiratory weakness reduces the volume of the initial breath. Expiratory muscle weakness limits pressure generation, while bulbar dysfunction may interfere with glottic closure and opening. The result is a progressively weaker cough.

An ineffective cough increases the risk of:

• Retained secretions
• Mucus plugging
• Atelectasis
• Pneumonia
• Airway obstruction
• Acute respiratory deterioration

Note: Cough impairment may become clinically important before significant hypoventilation develops.

Peak Cough Flow

Peak cough flow provides an objective measurement of cough effectiveness. A peak cough flow below approximately 270 L/min is generally considered inadequate and should prompt consideration of assisted coughing.

Values between approximately 160 and 270 L/min may sometimes be sufficient when the patient is clinically stable. However, cough strength often declines temporarily during respiratory infections.

A patient with a peak cough flow of 200 L/min may manage secretions adequately under normal circumstances but become unable to clear secretions during pneumonia or another acute illness. This is why respiratory infections can become particularly dangerous in ALS.

Assisted Coughing

Assisted cough techniques can improve secretion clearance when the patient cannot generate adequate expiratory flow independently. Manual cough assistance may involve applying pressure to the abdomen or thorax during the expiratory phase of coughing.

This externally applied pressure supplements weakened expiratory muscles and helps generate greater expiratory airflow. Assisted coughing may be combined with lung-volume recruitment to improve effectiveness.

Mechanical Insufflation-Exsufflation

Mechanical insufflation-exsufflation is frequently used to assist cough in patients with ALS and other neuromuscular diseases. The device first delivers positive pressure to inflate the lungs. It then rapidly switches to negative pressure, producing a high expiratory flow that simulates a cough.

The treatment can help mobilize secretions when the patient lacks sufficient inspiratory or expiratory muscle strength.

Pressures are generally introduced at tolerable levels and adjusted as needed to achieve effective secretion clearance. Bulbar dysfunction may complicate treatment because excessive pressure can promote upper-airway closure.

The therapist should therefore evaluate the patient’s response carefully and adjust therapy according to cough effectiveness and tolerance. During pneumonia or increased sputum production, mechanical insufflation-exsufflation may need to be performed more frequently than during the patient’s normal maintenance schedule.

Lung-Volume Recruitment

Lung-volume recruitment techniques help patients take breaths larger than they could generate spontaneously.

These techniques may help:

• Maintain chest wall flexibility
• Expand areas of atelectasis
• Increase inspiratory volume before coughing
• Improve peak cough flow
• Support secretion clearance
• Preserve lung expansion

Note: Lung-volume recruitment is often introduced when FVC falls below approximately 40% predicted or below approximately 1.25 L in an adult.

Breath Stacking

Breath stacking is a form of lung-volume recruitment in which the patient takes consecutive inspirations without fully exhaling between them. The successive breaths increase lung volume beyond what the patient could achieve with a single spontaneous inspiration.

The patient may then cough from the larger lung volume. A larger initial inspiration can produce stronger expiratory airflow during coughing. In selected patients, volume-controlled ventilation through a mouthpiece can also be used to facilitate breath stacking.

Why Incentive Spirometry May Be Limited

Incentive spirometry is commonly used in many hospitalized patients to encourage deep breathing. However, it may provide limited benefit when the primary problem is severe respiratory muscle weakness.

A patient with ALS may understand the instructions and attempt a deep breath but still lack the muscle strength needed to achieve meaningful lung expansion.

Lung-volume recruitment techniques that provide external assistance are therefore often more appropriate.

Bulbar Dysfunction and Aspiration

Bulbar muscles help control speech, swallowing, glottic function, and airway protection. ALS involving these muscles can lead to dysphagia and aspiration.

Signs of bulbar impairment may include:

• Difficulty swallowing
• Coughing while eating
• Choking
• Changes in speech
• Weak voice
• Difficulty controlling oral secretions

Aspiration is especially concerning in ALS because patients may already have weak respiratory muscles and an impaired cough.

Even a relatively small aspiration event may produce significant respiratory consequences if the patient cannot clear material from the airway. Aspiration pneumonia can rapidly increase respiratory workload and precipitate ventilatory failure.

Nocturnal Hypoventilation

Sleep-related hypoventilation commonly develops before daytime respiratory failure. During sleep, respiratory drive changes and accessory muscle activity decreases. A weakened diaphragm may therefore become unable to maintain sufficient tidal volume.

Symptoms associated with nocturnal hypoventilation may include:

• Morning headaches
• Excessive daytime sleepiness
• Fatigue
• Poor concentration
• Frequent awakening
• Restless sleep
• Dyspnea
• Orthopnea

Note: Sleep studies may be performed to evaluate nocturnal breathing disturbances. Polysomnography can identify sleep-related hypoventilation and help determine appropriate ventilatory support.

Noninvasive Ventilation

Noninvasive ventilation is one of the most important respiratory therapies used in ALS. Unlike invasive ventilation, NIV provides positive-pressure assistance without an endotracheal or tracheostomy tube.

Interfaces may include:

• Nasal masks
• Oronasal masks
• Total-face masks
• Mouthpieces

Noninvasive ventilation reduces the workload placed on weakened respiratory muscles and supports tidal volume and alveolar ventilation. It is commonly introduced initially during sleep because nocturnal hypoventilation often develops first.

As ALS progresses, ventilatory assistance may eventually be extended into daytime hours. NIV has been associated with improvements in quality of life and survival in appropriately selected patients with ALS.

Indications for Nocturnal Ventilatory Support

Nocturnal noninvasive ventilation may be considered when symptoms or objective evidence of respiratory insufficiency appear.

Supporting findings may include:

• Symptoms of hypoventilation
• Awake oxygen saturation below approximately 95% on room air
• Awake end-tidal PCO₂ above approximately 45 torr
• Significant sleep-related oxygen desaturation
• Apnea-hypopnea index above approximately 10 events per hour

Note: The decision should not be based exclusively on a single threshold. Symptoms, pulmonary function, respiratory muscle strength, gas exchange, sleep findings, and overall disease progression should be considered together.

Why CPAP Is Not Enough for Hypoventilation

Continuous positive airway pressure maintains positive pressure throughout the respiratory cycle. It is highly useful for conditions involving upper-airway collapse, particularly obstructive sleep apnea.

However, CPAP does not provide the same ventilatory assistance as bilevel or other forms of noninvasive ventilation. In ALS, the primary problem is often inadequate ventilation caused by weak respiratory muscles.

These patients may need inspiratory pressure assistance to increase tidal volume and improve carbon dioxide elimination. CPAP alone does not directly correct this problem.

Daytime Ventilatory Support

As respiratory muscle weakness progresses, nighttime support may eventually become insufficient.

Daytime noninvasive ventilation may be considered when:

• End-tidal PCO₂ exceeds approximately 50 torr
• Awake oxygen saturation remains below approximately 92%
• Persistent dyspnea improves with ventilatory assistance
• Respiratory muscle weakness becomes severe
• The patient increasingly depends on ventilatory support

Mouthpiece ventilation can be useful in selected patients who retain sufficient bulbar function. The patient can access the mouthpiece when ventilatory assistance is needed without continuously wearing a mask.

Volume-controlled mouthpiece ventilation may also assist with lung-volume recruitment and breath stacking.

Monitoring Noninvasive Ventilation

Starting NIV is only the beginning of the process. Patients should be reassessed to determine whether treatment is actually improving ventilation.

Monitoring may include:

• Respiratory rate
• Tidal volume
• Minute ventilation
• Oxygen saturation
• Carbon dioxide levels
• Work of breathing
• Patient comfort
• Mask leak
• Patient-ventilator synchrony

Note: Interface fit is also important. Significant leakage may reduce effective support, while excessive mask pressure can lead to discomfort or skin breakdown. Humidification may improve comfort during prolonged use.

Oxygen Therapy in ALS

Supplemental oxygen should not automatically be used as the primary treatment for low oxygen saturation in ALS. Hypoxemia may occur because respiratory muscle weakness causes alveolar hypoventilation.

In this situation, the underlying problem is insufficient ventilation. Simply administering oxygen may improve the saturation reading without correcting carbon dioxide retention or inadequate alveolar ventilation.

Ventilatory support may be required to increase tidal volume, reduce PCO₂, and improve oxygenation. Low oxygen saturation may also result from retained secretions, mucus plugging, or atelectasis.

When airway clearance is the underlying problem, cough assistance and lung expansion should be intensified rather than relying solely on supplemental oxygen. Oxygen may still be used when specifically indicated, but clinicians should identify and treat the cause of hypoxemia.

Acute Respiratory Illness

Pneumonia, aspiration, surgery, or another acute illness can rapidly destabilize a patient with ALS. Respiratory muscle strength that was sufficient under normal conditions may become inadequate when respiratory workload increases.

Infection can also increase mucus production at a time when the patient’s cough is already weak.

Signs of deterioration may include:

• Increasing dyspnea
• Tachypnea
• Orthopnea
• Weak cough
• Increasing sputum
• Falling oxygen saturation
• Rising carbon dioxide
• Declining vital capacity
• Difficulty swallowing
• Increased work of breathing

Note: Airway-clearance therapy should usually be intensified during periods of increased secretion production. Mechanical insufflation-exsufflation may need to be performed more frequently, while ventilatory support may also need adjustment.

Progression to Respiratory Failure

Advanced ALS can ultimately produce inadequate ventilation during both wakefulness and sleep.

Signs suggesting severe respiratory muscle failure may include:

• Vital capacity below approximately 1 L
• Vital capacity below approximately 15 mL/kg
• Severely reduced MIP
• MEP below approximately 40 cm H₂O
• Inability to cough effectively
• Hypercapnia
• Respiratory acidosis
• Persistent hypoxemia
• Inability to protect the airway
• Severe dysphagia
• Aspiration pneumonia
• Respiratory distress

Note: The need for intubation and invasive mechanical ventilation depends on the overall clinical condition and goals of care.

Tracheostomy and Invasive Ventilation

Noninvasive ventilation is generally preferred when it can safely provide adequate support. However, some patients eventually require invasive ventilation through a tracheostomy.

Tracheostomy ventilation may be considered when:

• NIV no longer provides sufficient ventilation
• Severe bulbar weakness prevents safe noninvasive support
• Airway protection is inadequate
• Secretions cannot be managed effectively
• Prolonged invasive ventilation is anticipated
• The patient chooses long-term invasive support

A tracheostomy introduces additional considerations involving humidification, suctioning, secretion management, communication, equipment care, and infection prevention.

Patients who remain cognitively intact may also require communication strategies such as speaking valves or other communication devices.

Nutrition and Respiratory Function

Nutrition becomes closely related to respiratory care as ALS progresses. Bulbar weakness may make swallowing difficult, while respiratory weakness can make eating physically exhausting. Patients may struggle to coordinate chewing, swallowing, and breathing.

Progressive weight loss may occur because of:

• Reduced oral intake
• Dysphagia
• Increased effort required for eating
• Increased respiratory workload

Note: Aspiration risk may also increase. Daytime ventilatory support can sometimes reduce respiratory workload during meals, but advanced swallowing dysfunction may eventually require consideration of enteral feeding.

Home Mechanical Ventilation

Long-term ventilatory support is frequently managed outside the hospital. Successful home ventilation requires preparation involving the patient, caregivers, respiratory therapists, physicians, and equipment providers.

Whenever possible, patients should be transitioned to the same ventilator they will use at home before hospital discharge. This allows the patient and caregivers to become familiar with the device while trained healthcare personnel remain available.

Home respiratory equipment may include:

• Noninvasive or invasive ventilator
• Mechanical insufflation-exsufflation device
• Suction equipment
• Humidification system
• Pulse oximeter
• Supplemental oxygen when specifically indicated
• Backup power source
• Hospital bed

Note: Patients who cannot maintain spontaneous ventilation for several hours may also require a backup ventilator.

Caregiver Education

Caregivers play an increasingly important role as ALS progresses.

Education should include:

• Ventilator operation
• Interface placement
• Tracheostomy care when applicable
• Airway suctioning
• Assisted coughing
• Mechanical insufflation-exsufflation
• Infection control
• Equipment troubleshooting
• Recognition of respiratory distress
• Emergency procedures
• Power outage planning

Note: A clear emergency plan is particularly important for patients who are highly dependent on mechanical ventilation.

Communication and Quality of Life

ALS may severely impair physical function while cognitive ability remains relatively preserved. This makes communication especially important. Bulbar weakness may reduce the patient’s ability to speak even before communication becomes impossible.

Communication strategies can include speaking valves, electronically assisted communication devices, eye-tracking systems, and other adaptive technologies. Respiratory treatment decisions should consider not only physiological measurements but also comfort, communication, mobility, independence, and the patient’s personal goals.

Planning for Progressive Disease

ALS has no curative treatment, and respiratory function generally declines over time. Advance planning should therefore occur before a respiratory crisis develops.

Patients and families may need to discuss future decisions involving:

• Noninvasive ventilation
• Tracheostomy ventilation
• Feeding tubes
• Emergency intubation
• Hospitalization
• Long-term home ventilation
• Resuscitation preferences
• Goals of care

Note: Early discussions give patients more opportunity to make informed decisions before severe respiratory weakness limits communication or creates an emergency situation.

Role of the Respiratory Therapist

Respiratory therapists play an important role throughout the progression of ALS. Responsibilities may include monitoring respiratory muscle function, assessing cough effectiveness, evaluating ventilation, applying noninvasive support, teaching airway-clearance techniques, and preparing patients for home respiratory equipment.

Respiratory care may involve:

• Measuring vital capacity
• Evaluating MIP and MEP
• Measuring peak cough flow
• Monitoring oxygen saturation
• Assessing carbon dioxide levels
• Performing lung-volume recruitment
• Teaching manually assisted coughing
• Managing mechanical insufflation-exsufflation
• Initiating and adjusting NIV
• Monitoring patient-ventilator interaction
• Supporting home ventilation
• Educating caregivers

Note: The goal is to identify respiratory decline early and match treatment to the patient’s changing needs rather than waiting for overt respiratory failure.

Amyotrophic Lateral Sclerosis Practice Questions

1. What is amyotrophic lateral sclerosis (ALS)?
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that causes degeneration of upper and lower motor neurons, resulting in progressive muscle weakness and paralysis.

2. What is another name for amyotrophic lateral sclerosis?
Amyotrophic lateral sclerosis is also known as Lou Gehrig disease.

3. What structures are primarily affected by ALS?
ALS primarily affects upper and lower motor neurons in the brain and spinal cord.

4. Why does ALS cause progressive muscle weakness?
ALS causes progressive muscle weakness because motor neurons degenerate and can no longer effectively stimulate voluntary skeletal muscles.

5. How does ALS affect the respiratory system?
ALS weakens the muscles responsible for breathing, coughing, swallowing, and airway protection, which can eventually lead to hypoventilation and respiratory failure.

6. What is the primary respiratory problem in ALS?
The primary respiratory problem in ALS is progressive respiratory muscle weakness.

7. What pulmonary function pattern is commonly seen in ALS?
ALS commonly produces a restrictive pulmonary function pattern due to respiratory muscle weakness.

8. Which lung volumes commonly decrease as ALS progresses?
Vital capacity and total lung capacity commonly decrease as respiratory muscle weakness progresses.

9. Why may residual volume remain relatively elevated in ALS?
Residual volume may remain relatively elevated because weakened expiratory muscles make it difficult to completely empty the lungs.

10. Why is serial measurement of vital capacity important in ALS?
Serial measurement of vital capacity helps identify progressive deterioration in respiratory muscle function over time.

11. What does maximum inspiratory pressure measure?
Maximum inspiratory pressure measures the strength of the inspiratory muscles, including the diaphragm and accessory muscles of inspiration.

12. What does maximum expiratory pressure measure?
Maximum expiratory pressure measures the strength of the expiratory muscles, including the abdominal muscles used during forced expiration and coughing.

13. What MIP value may indicate severe inspiratory muscle weakness in ALS?
An MIP that becomes less negative than approximately −20 to −25 cm H₂O may indicate severe inspiratory muscle weakness.

14. What vital capacity may indicate severely limited ventilatory capacity?
A vital capacity below approximately 10 to 15 mL/kg predicted body weight may indicate severely limited ventilatory capacity.

15. What is sniff nasal inspiratory pressure used to assess?
Sniff nasal inspiratory pressure is used to assess inspiratory muscle strength in patients with neuromuscular weakness.

16. What SNIP value has been associated with a poor prognosis in ALS?
A sniff nasal inspiratory pressure below approximately 40 cm H₂O has been associated with increased mortality in ALS.

17. What is one of the earliest respiratory symptoms of ALS?
Exertional dyspnea is one of the earliest respiratory symptoms associated with progressive respiratory muscle weakness.

18. What does orthopnea suggest in a patient with ALS?
Orthopnea strongly suggests significant diaphragmatic weakness.

19. Why can breathing become more difficult when a patient with ALS lies flat?
Lying flat causes the abdominal contents to push upward against the diaphragm, making ventilation more difficult when the diaphragm is weak.

20. What positional change in vital capacity may suggest diaphragmatic weakness?
A decrease of approximately 10% to 20% in vital capacity when moving from an upright to a supine position may suggest diaphragmatic weakness.

21. Why is coughing often impaired in ALS?
Coughing becomes impaired because inspiratory weakness limits the initial breath, expiratory weakness reduces cough pressure, and bulbar weakness may impair glottic closure.

22. What peak cough flow suggests that cough assistance should be considered?
A peak cough flow below approximately 270 L/min suggests that cough assistance should be considered.

23. What MEP value may indicate the need for assisted coughing?
An MEP below approximately 60 cm H₂O may indicate the need for an assisted cough regimen.

24. What is mechanical insufflation-exsufflation?
Mechanical insufflation-exsufflation is an airway-clearance technique that delivers positive pressure followed by negative pressure to simulate a cough and help remove secretions.

25. Why are respiratory infections especially dangerous for patients with ALS?
Respiratory infections are especially dangerous because increased secretions and respiratory workload can overwhelm weakened respiratory muscles and an already ineffective cough.

26. What is peak cough flow used to evaluate in ALS?
Peak cough flow is used to evaluate how effectively a patient can generate the expiratory flow needed to clear secretions.

27. Why may a peak cough flow between 160 and 270 L/min become inadequate during an infection?
A respiratory infection can increase secretion production and respiratory workload, making a marginally effective cough insufficient for airway clearance.

28. What is manually assisted coughing?
Manually assisted coughing is a technique in which external pressure is applied to the chest or abdomen during coughing to increase expiratory flow.

29. What is lung-volume recruitment?
Lung-volume recruitment is a technique used to help a patient take a larger-than-normal inspiration in order to improve lung expansion and cough effectiveness.

30. When should lung-volume recruitment be considered in an adult with ALS?
Lung-volume recruitment should be considered when FVC falls below approximately 40% predicted or below about 1.25 L.

31. What is breath stacking?
Breath stacking is a technique in which consecutive inspirations are taken without fully exhaling between breaths to increase lung volume.

32. How can breath stacking improve cough effectiveness?
Breath stacking increases the volume of air available before coughing, which can help produce greater expiratory flow.

33. Why may incentive spirometry be less effective in advanced ALS?
Incentive spirometry may be less effective because the patient may lack the respiratory muscle strength needed to generate a sufficiently deep inspiration.

34. What role does bulbar dysfunction play in ALS respiratory care?
Bulbar dysfunction can impair swallowing, glottic closure, airway protection, speech, and effective coughing.

35. Why does dysphagia increase respiratory risk in ALS?
Dysphagia increases the risk of aspiration, which can lead to pneumonia and rapid respiratory deterioration.

36. Why may aspiration pneumonia cause severe deterioration in a patient with ALS?
Aspiration pneumonia increases secretion burden and respiratory workload in a patient who may already have limited ventilatory reserve and an ineffective cough.

37. What is nocturnal hypoventilation?
Nocturnal hypoventilation is inadequate alveolar ventilation during sleep that results from respiratory muscle weakness.

38. Why may nocturnal hypoventilation develop before daytime respiratory failure?
Sleep reduces respiratory drive and accessory muscle activity, which can expose respiratory muscle weakness before daytime ventilation becomes inadequate.

39. What symptoms may suggest nocturnal hypoventilation in ALS?
Symptoms may include morning headaches, fatigue, excessive daytime sleepiness, poor concentration, disturbed sleep, dyspnea, and orthopnea.

40. What test can be used to evaluate sleep-related breathing problems in ALS?
Polysomnography can be used to evaluate sleep-disordered breathing and nocturnal hypoventilation.

41. What is the preferred ventilatory support for many patients with ALS who develop nocturnal hypoventilation?
Noninvasive positive-pressure ventilation is commonly used to support ventilation during sleep.

42. Why is CPAP generally not sufficient for ALS-related hypoventilation?
CPAP maintains positive airway pressure but does not provide enough inspiratory assistance to correct inadequate ventilation caused by respiratory muscle weakness.

43. What awake end-tidal PCO₂ value may support initiation of nocturnal noninvasive ventilation?
An awake end-tidal PCO₂ above approximately 45 torr may support initiation of nocturnal noninvasive ventilation.

44. What awake oxygen saturation may support initiation of nocturnal noninvasive ventilation?
An awake oxygen saturation below approximately 95% on room air may support initiation of nocturnal noninvasive ventilation.

45. What apnea-hypopnea index may support initiation of nocturnal ventilatory support?
An apnea-hypopnea index above approximately 10 events per hour may support initiation of nocturnal ventilatory support.

46. Why is noninvasive ventilation beneficial in ALS?
Noninvasive ventilation reduces the workload on weakened respiratory muscles and improves ventilation without immediately requiring an artificial airway.

47. When may daytime noninvasive ventilation become necessary?
Daytime noninvasive ventilation may become necessary when respiratory weakness progresses and ventilation is no longer adequate while the patient is awake.

48. What end-tidal PCO₂ value may indicate the need for daytime ventilatory support?
An end-tidal PCO₂ above approximately 50 torr may indicate the need for daytime ventilatory support.

49. What awake oxygen saturation may indicate the need for daytime ventilatory support?
An awake oxygen saturation that remains below approximately 92% may indicate the need for daytime ventilatory support.

50. What type of daytime interface may be useful for some patients with ALS?
A mouthpiece interface may be useful for daytime ventilation in patients who retain sufficient bulbar function to form an effective lip seal.

51. Why is supplemental oxygen alone not an adequate treatment for ALS-related hypoventilation?
Supplemental oxygen may improve oxygen saturation without correcting inadequate alveolar ventilation or carbon dioxide retention.

52. What should be treated when low oxygen saturation is caused by mucus plugging in ALS?
Airway clearance and lung expansion should be improved to correct the underlying mucus plugging and atelectasis.

53. How can secretion retention contribute to hypoxemia in ALS?
Retained secretions can cause mucus plugging and atelectasis, which impair ventilation and reduce oxygenation.

54. Why should carbon dioxide levels be monitored as ALS progresses?
Rising carbon dioxide levels can indicate worsening alveolar hypoventilation from respiratory muscle weakness.

55. What can happen when tidal volume falls but respiratory rate increases?
Minute ventilation may appear adequate while effective alveolar ventilation decreases because more of each breath ventilates dead space.

56. Why can rapid shallow breathing become ineffective in advanced ALS?
Small tidal volumes increase the proportion of ventilation lost to anatomical dead space, reducing effective alveolar ventilation.

57. What is the main goal of ventilatory support in ALS?
The main goal is to maintain adequate ventilation while reducing the workload placed on weakened respiratory muscles.

58. What factors should be considered when selecting ventilatory support for a patient with ALS?
Respiratory effort, airway protection, neurological status, secretion burden, bulbar function, and overall clinical stability should be considered.

59. Why must patients on noninvasive ventilation be reassessed after therapy begins?
Reassessment is needed to confirm that ventilation, comfort, gas exchange, and patient-ventilator interaction are improving.

60. What parameters should be monitored during noninvasive ventilation?
Respiratory rate, tidal volume, minute ventilation, oxygenation, carbon dioxide elimination, work of breathing, leaks, and patient comfort should be monitored.

61. Why are mask leaks important during noninvasive ventilation?
Significant leaks can reduce effective ventilatory support and impair patient-ventilator synchrony.

62. What complication can occur with prolonged use of a noninvasive ventilation mask?
Prolonged mask use can cause skin irritation or pressure-related breakdown at facial contact points.

63. Why may humidification be helpful during prolonged noninvasive ventilation?
Humidification can reduce airway dryness and improve patient comfort.

64. When might tracheostomy ventilation be considered in ALS?
Tracheostomy ventilation may be considered when noninvasive ventilation is ineffective, contraindicated, impractical, or no longer able to meet the patient’s needs.

65. How can severe bulbar weakness affect the use of noninvasive ventilation?
Severe bulbar weakness can impair airway protection, swallowing, secretion management, and the ability to tolerate or use noninvasive interfaces effectively.

66. What respiratory finding may favor intubation in a patient with ALS?
Severe respiratory failure with very low vital capacity, hypercapnia, inability to protect the airway, or inability to clear secretions may favor intubation.

67. Why is aspiration especially concerning in advanced ALS?
Aspiration can cause pneumonia in a patient who may already have weak respiratory muscles, poor airway protection, and limited cough effectiveness.

68. How can mouthpiece ventilation assist some patients with ALS?
Mouthpiece ventilation can provide daytime ventilatory support while also allowing supported breaths for lung-volume recruitment and breath stacking.

69. What patient ability is important for successful mouthpiece ventilation?
The patient must retain enough bulbar function to form an adequate lip seal around the mouthpiece.

70. Why might daytime ventilatory support improve eating in ALS?
Daytime ventilation can reduce respiratory muscle workload and make it easier to coordinate breathing with chewing and swallowing.

71. Why can weight loss occur as ALS progresses?
Weight loss may result from dysphagia, reduced intake, increased effort required for eating, and increased respiratory workload.

72. When might enteral feeding be considered in ALS?
Enteral feeding may be considered when progressive swallowing dysfunction makes oral intake unsafe or inadequate.

73. Why is it helpful to transition a patient to the home ventilator before discharge?
Using the home ventilator before discharge allows the patient and caregivers to learn the equipment while professional support is still readily available.

74. When should a backup ventilator be considered for home use?
A backup ventilator should be considered when the patient cannot sustain spontaneous ventilation for four or more hours or when rapid replacement of a failed ventilator cannot be assured.

75. What should caregiver education include for home respiratory management of ALS?
Caregiver education should include ventilator operation, airway clearance, suctioning, equipment troubleshooting, infection control, emergency procedures, and recognition of respiratory distress.

76. Why is continuous pulse oximetry useful in advanced ALS?
Continuous pulse oximetry can help detect persistent or episodic hypoxemia as respiratory weakness becomes more severe.

77. Why should end-tidal carbon dioxide be monitored in advanced ALS?
End-tidal carbon dioxide helps identify worsening hypoventilation and carbon dioxide retention.

78. What does a progressively less negative MIP indicate?
A progressively less negative MIP indicates worsening inspiratory muscle weakness.

79. Why is a single respiratory measurement often insufficient in ALS?
ALS is progressive, so trends over time provide more useful information than one isolated measurement.

80. Why can an acute illness trigger respiratory failure in ALS?
An acute illness increases respiratory workload and secretion burden, which can overwhelm weakened respiratory muscles.

81. What is microatelectasis?
Microatelectasis refers to small areas of lung collapse that can develop when patients cannot take sufficiently deep breaths.

82. How can lung-volume recruitment help prevent microatelectasis?
Lung-volume recruitment helps expand underinflated lung regions and maintain more complete lung inflation.

83. Why is airway protection a major concern in patients with bulbar ALS?
Bulbar weakness can impair swallowing and glottic function, increasing the risk of aspiration.

84. What is the purpose of manual thoracoabdominal compression during coughing?
Manual thoracoabdominal compression increases expiratory force to improve cough flow.

85. Why may mechanical insufflation-exsufflation be less effective in severe bulbar dysfunction?
Severe bulbar dysfunction can cause upper-airway closure during assisted cough therapy, limiting airflow.

86. What is the relationship between MEP and cough strength?
Lower MEP values indicate weaker expiratory muscles and generally correspond with reduced ability to generate an effective cough.

87. Why is an intact upper airway important for some forms of noninvasive ventilation?
An intact and adequately controlled upper airway helps maintain effective ventilation and reduce aspiration risk.

88. What is the role of portable ventilators in long-term ALS care?
Portable ventilators provide ongoing ventilatory support while allowing greater mobility and home use.

89. Why is suction equipment often needed in advanced ALS?
Suction equipment may be needed because weak cough and bulbar dysfunction can make spontaneous secretion clearance inadequate.

90. What emergency planning is important for ventilator-dependent patients with ALS?
Emergency planning should address ventilator failure, power outages, backup equipment, and access to urgent assistance.

91. Why is communication support important in advanced ALS?
Patients may lose the ability to speak while remaining cognitively able to communicate, making alternative communication methods essential.

92. What communication devices may be used in advanced ALS?
Speaking valves, electronic communication devices, and eye-tracking systems may be used depending on the patient’s condition.

93. Why should goals-of-care discussions occur before severe respiratory failure develops?
Early discussions allow patients to make informed decisions about ventilation, feeding, resuscitation, and long-term care before a crisis occurs.

94. What role does respiratory therapy play in home ALS management?
Respiratory therapists help manage ventilation, airway clearance, equipment use, monitoring, and caregiver education.

95. Why is noninvasive ventilation generally preferred before tracheostomy ventilation?
Noninvasive ventilation can support breathing without requiring an artificial airway when it remains effective and safe.

96. What does hypercapnia indicate in a patient with ALS?
Hypercapnia indicates inadequate alveolar ventilation and may reflect advanced respiratory muscle weakness.

97. What acid-base disturbance may develop with advanced hypoventilation in ALS?
Respiratory acidosis may develop as carbon dioxide accumulates because of inadequate ventilation.

98. Why can normal-appearing lungs still be associated with severe respiratory failure in ALS?
The lungs may be structurally normal, but profound respiratory muscle weakness can prevent adequate ventilation.

99. What is the overall goal of respiratory management in ALS?
The overall goal is to preserve effective ventilation, airway clearance, airway protection, and respiratory comfort as the disease progresses.

100. Why is early recognition of respiratory decline important in ALS?
Early recognition allows timely initiation of cough assistance, lung-volume recruitment, noninvasive ventilation, and other supportive measures before severe respiratory failure develops.

Final Thoughts

Amyotrophic lateral sclerosis (ALS) causes progressive motor neuron loss that eventually weakens the muscles responsible for ventilation, coughing, swallowing, and airway protection. Respiratory management therefore requires repeated assessment throughout the course of the disease.

Vital capacity, respiratory muscle pressures, peak cough flow, symptoms, gas exchange, and sleep-related breathing abnormalities can help identify deterioration before severe respiratory failure develops. Assisted coughing, mechanical insufflation-exsufflation, lung-volume recruitment, and noninvasive ventilation can support respiratory function as weakness progresses.

Advanced disease may eventually require daytime ventilation or invasive support, making early planning, caregiver education, airway management, and patient-centered decision-making essential components of long-term care.